2025-12-23 - Analysis Report
Okay, here's a comprehensive analysis of Air Products and Chemicals Inc. (APD), based on the data you provided.

**1) Return Rate Comparison:**

*   **Company Overview:** Air Products and Chemicals Inc. (APD) is a leading industrial gases company, providing atmospheric and process gases, and related equipment to various industries.
*   **APD Cumulative Return:** -11.12%
*   **S&P 500 (VOO) Cumulative Return:** 100.88%
*   **Divergence:** -112.0 (Relative Divergence: 2.2)

**Analysis:** APD has significantly underperformed the S&P 500. The divergence of -112.0 indicates a substantial difference in returns. The relative divergence of 2.2 suggests that the current divergence is near its minimum historically.

**Alpha, Beta Analysis Table:**

| Year       | CAGR  | MDD   | Alpha   | Beta  | Cap(B) |
|------------|-------|-------|---------|-------|--------|
| 2015-2017  | 24.0% | 64.6% | -4.0%   | 0.1   | 37.3   |
| 2016-2018  | 21.0% | 69.5% | 6.0%    | 0.2   | 36.3   |
| 2017-2019  | 39.0% | 69.9% | 17.0%   | 0.7   | 53.4   |
| 2018-2020  | 21.0% | 77.7% | -3.0%   | 0.6   | 62.0   |
| 2019-2021  | 45.0% | 77.7% | -2.0%   | 0.7   | 69.1   |
| 2020-2022  | 6.0%  | 79.4% | 7.0%    | 0.8   | 70.0   |
| 2021-2023  | -27.0% | 79.4% | -29.0%  | 0.8   | 62.2   |
| 2022-2024  | -39.0% | 79.4% | -59.0%  | 0.9   | 65.9   |
| 2023-2025  | -68.0% | 74.8% | -133.0% | 2.3   | 54.5   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) has declined significantly in recent years, indicating a slowdown in growth. The recent period (2023-2025) shows a substantial negative growth rate.
*   **MDD:** The Maximum Drawdown (MDD) remains high, indicating significant potential for losses from peak to trough.
*   **Alpha:** Alpha, which measures performance relative to a benchmark (likely the S&P 500), has been negative in several periods, especially recently, indicating underperformance.  The most recent period shows a very large negative alpha.
*   **Beta:** Beta has been increasing, particularly in the last period, suggesting that the stock is becoming more volatile relative to the market and increasingly sensitive to market movements.
*   **Cap(B):** Market capitalization has fluctuated, reflecting the company's performance.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 239.96
*   **Last Market Data:** Price: 244.78, Previous Close: 239.96, Change: 2.01
*   **5-day SMA:** 243.47
*   **20-day SMA:** 250.079
*   **60-day SMA:** 254.9732

**Analysis:**  The stock price is currently below all three moving averages (5-day, 20-day, and 60-day SMA), which is generally considered a bearish signal. The recent price increase to 244.78 shows a short-term bounce, but the overall trend suggests downward momentum.

**3) RSI, PPO, and Expected Return:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 35.38 (Approaching oversold territory)
*   **PPO:** -0.237
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -0.8 (Indicates short-term decline)
*   **Expected Return (%):** -1444.7 (Substantial negative expected return)

**Analysis:**

*   The MRI suggests a medium investment recommendation based on overall risk, but this conflicts with other indicators.
*   The RSI is approaching oversold territory (typically below 30), suggesting a potential for a rebound, but is not yet at that level.
*   The PPO is negative, indicating that the short-term moving average is below the long-term moving average, confirming the downward trend.
*   The large negative expected return is a significant concern, suggesting that current models predict continued underperformance compared to the S&P 500.
*   The recent divergence change confirms the recent short-term decline.

**4) Recent News & Significant Events:**

*   **Bernstein reiterates outperform:** Positive signal
*   **Thrivent Financial lowers holdings:** Negative signal
*   **Forbes: What's Next With APD Stock After A 25% Drop?** Negative signal
*   **APD stock is down 10% today:** Negative signal
*   **Air Products (APD) Stock Hits 52‑Week Low After Yara Hydrogen Deal:** Negative signal
*   **Air Products Stock Becomes Top Decliner Among S&P 500 Companies Today:** Negative signal

**Analysis:** Recent news is mixed but largely negative. While Bernstein's reiteration of an "outperform" rating provides some positive sentiment, several articles highlight stock declines, a 52-week low, and reduced holdings by Thrivent Financial. The negative news likely contributes to investor concern.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (~2.13)
*   **Target Price:** $292.86 (avg) / $340.00 (high) / $245.00 (low)
*   **Recent Rating Changes:** Not provided (indicated by empty parentheses)

**Analysis:**  Despite the recent poor performance, the analyst consensus remains a "Buy" with an average target price of $292.86. This suggests that analysts believe the stock is undervalued and has the potential to recover.  However, the current price is significantly below the average target, indicating either a strong belief in future improvement or a potential lag in analyst adjustments to recent performance.

**5) Recent Earnings Analysis:**

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-07-31 | 3.2    | 3.02 B$    |
| 2025-05-01 | -7.77  | 2.92 B$    |
| 2025-02-06 | 2.77   | 2.93 B$    |
| 2024-08-01 | 3.13   | 2.99 B$    |
| 2025-07-31 | 3.13   | 2.99 B$    |

**Analysis:** The earnings data shows mixed results. While some quarters show positive EPS, the period of 2025-05-01 shows a significant loss. Revenue has been relatively stable, fluctuating around $3 billion. The volatility in EPS suggests potential challenges in profitability.

**6) Financial Information:**

Revenue and Profitability:

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $3.17B     | 32.25%        |
| 2025-06-30   | $3.02B     | 32.51%        |
| 2025-03-31   | $2.92B     | 29.57%        |
| 2024-12-31   | $2.93B     | 31.21%        |
| 2024-09-30   | $3.19B     | 33.98%        |

Capital and Profitability:

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-09-30   | $15.02B    | 0.03%     |
| 2025-06-30   | $15.54B    | 4.59%     |
| 2025-03-31   | $14.70B    | -11.77%    |
| 2024-12-31   | $16.69B    | 3.70%     |
| 2024-09-30   | $17.04B    | 11.45%    |

**Analysis:**

*   **Revenue:** Revenue has been relatively stable in the $2.9B to $3.2B range, with a slight dip in the middle quarters.
*   **Profit Margin:** Profit margins are relatively healthy, ranging from 29.57% to 33.98%.
*   **Equity:** Equity has fluctuated, indicating changes in the company's net assets.
*   **ROE:** Return on Equity (ROE) has been volatile, with a significant negative value in 2025-03-31 and low values in recent quarters. This suggests challenges in generating profit from shareholder equity.

**7) Comprehensive Analysis (Summary):**

APD is currently facing significant challenges. The stock has significantly underperformed the S&P 500, with a large negative divergence. Recent performance shows declining CAGR and negative alpha. The stock price is below key moving averages. While the RSI suggests a potential for a rebound, the negative PPO and very large negative expected return are concerning.

Recent news and events are mixed, with more negative than positive headlines. Analyst consensus remains a "Buy," but this contrasts with the stock's recent performance. Earnings and ROE have been volatile. While revenue and profit margins remain relatively stable, the lack of consistent profitability is a concern.

**Overall Recommendation:**

Given the negative performance, negative expected return, and mixed news, a **cautious approach is warranted**. While analysts maintain a "Buy" rating, the data suggests significant risk. Potential investors should carefully consider the negative indicators and conduct further due diligence before investing. Current holders might consider re-evaluating their position based on their risk tolerance and investment horizon. The Bernstein reiteration of outperform does offer a shred of positivity.



**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.